General Motors Investment Management’s Emergent Biosolutions EBS Stock Holding History

General Motors Investment Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-13,870	Closed	-$399K	–	190
2015 Q1	$399K	Buy	13,870 +1,998	+17%	+$57.3K	0.03%	589
2014 Q4	$323K	Hold	11,872	–	–	0.03%	666
2014 Q3	$253K	Hold	11,872	–	–	0.02%	731
2014 Q2	$267K	Sell	11,872 -1,072	-8%	-$25K	0.02%	747
2014 Q1	$327K	Sell	12,944 -1,215	-9%	-$30.7K	0.03%	598
2013 Q4	$326K	Buy	14,159 +2,219	+19%	+$46.3K	0.03%	633
2013 Q3	$227K	Hold	11,940	–	–	0.02%	759
2013 Q2	$172K	Buy	+11,940	New	+$173K	0.01%	824

Other funds holding EBS

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

FMA

Fiduciary Management Associates Chicago, Illinois $1.53B AUM 4.47% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

General Motors Investment Management's EBS Position: Q2 2015 in Review

General Motors Investment Management sold out of Emergent Biosolutions (EBS) in Q2 2015, closing a stake of 13,870 shares — an estimated $399K sold.

General Motors Investment Management first reported a position in EBS in Q2 2013 and held it in 8 quarters. The position peaked at $399K in Q1 2015. 185 funds tracked by Wall St. Rank hold EBS as of Q2 2015.

General Motors Investment Management reported no remaining Emergent Biosolutions position as of Q2 2015 after selling out during the quarter.
General Motors Investment Management sold 13,870 Emergent Biosolutions shares in Q2 2015, an estimated $399K.
General Motors Investment Management first reported a position in Emergent Biosolutions in Q2 2013 and held it in 8 quarters.
General Motors Investment Management's Emergent Biosolutions position peaked at $399K in Q1 2015.
185 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2015.

Based on General Motors Investment Management's 13F filing for Q2 2015, filed 5 Aug 2015.